These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31795252)

  • 1. Triterpenes and Aromatic Meroterpenoids with Antioxidant Activity and Neuroprotective Effects from
    Wang C; Liu X; Lian C; Ke J; Liu J
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective and antioxidant lanostanoid triterpenes from the fruiting bodies of Ganoderma atrum.
    Qiu J; Wang X; Song C
    Fitoterapia; 2016 Mar; 109():75-9. PubMed ID: 26709153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triterpenes and Meroterpenes with Neuroprotective Effects from Ganoderma leucocontextum.
    Chen H; Zhang J; Ren J; Wang W; Xiong W; Zhang Y; Bao L; Liu H
    Chem Biodivers; 2018 May; 15(5):e1700567. PubMed ID: 29603608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antioxidant potentials of an ethanolic extract of Ganoderma lucidum in rat mammary carcinogenesis.
    Deepalakshmi K; Mirunalini S; Krishnaveni M; Arulmozhi V
    Chin J Nat Med; 2013 Nov; 11(6):621-7. PubMed ID: 24345503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3.
    Hsieh TC; Wu JM
    Int J Mol Med; 2011 Dec; 28(6):1065-9. PubMed ID: 21887458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lanostane triterpenes from the fruiting bodies of Ganoderma lucidum and their inhibitory effects on adipocyte differentiation in 3T3-L1 Cells.
    Lee I; Seo J; Kim J; Kim H; Youn U; Lee J; Jung H; Na M; Hattori M; Min B; Bae K
    J Nat Prod; 2010 Feb; 73(2):172-6. PubMed ID: 20039640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accessing biological actions of Ganoderma secondary metabolites by in silico profiling.
    Grienke U; Kaserer T; Pfluger F; Mair CE; Langer T; Schuster D; Rollinger JM
    Phytochemistry; 2015 Jun; 114():114-24. PubMed ID: 25457486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australeols A-F, neuroprotective meroterpenoids from Ganoderma australe.
    Zhang JJ; Dong Y; Qin FY; Cheng YX
    Fitoterapia; 2019 Apr; 134():250-255. PubMed ID: 30825574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum.
    Lee I; Ahn B; Choi J; Hattori M; Min B; Bae K
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6603-7. PubMed ID: 21924611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganospirones A-G, seven undescribed spiro-meroterpenoids from Ganoderma lucidum and their biological activities.
    Li D; Li SH; Gao Q; Luo Q; Cheng YX
    Phytochemistry; 2024 Nov; 227():114226. PubMed ID: 39047853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cancer Effects of a Neutral Triterpene Fraction from Ganoderma lucidum and its Active Constituents on SW620 Human Colorectal Cancer Cells.
    Li P; Liu L; Huang S; Zhang Y; Xu J; Zhang Z
    Anticancer Agents Med Chem; 2020; 20(2):237-244. PubMed ID: 31749435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new lanostane-type triterpene from the fruiting bodies of Ganoderma lucidum.
    Luo J; Zhao YY; Li ZB
    J Asian Nat Prod Res; 2002 Jun; 4(2):129-34. PubMed ID: 12067158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spiro Meroterpenoids from Ganoderma applanatum.
    Luo Q; Wei XY; Yang J; Luo JF; Liang R; Tu ZC; Cheng YX
    J Nat Prod; 2017 Jan; 80(1):61-70. PubMed ID: 27996259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lanostane triterpenoids with cytotoxic activities from the fruiting bodies of Ganoderma hainanense.
    Ma QY; Luo Y; Huang SZ; Guo ZK; Dai HF; Zhao YX
    J Asian Nat Prod Res; 2013 Nov; 15(11):1214-9. PubMed ID: 23909866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triterpenes and meroterpenes from Ganoderma lucidum with inhibitory activity against HMGs reductase, aldose reductase and α-glucosidase.
    Chen B; Tian J; Zhang J; Wang K; Liu L; Yang B; Bao L; Liu H
    Fitoterapia; 2017 Jul; 120():6-16. PubMed ID: 28527898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triterpene antioxidants from ganoderma lucidum.
    Zhu M; Chang Q; Wong LK; Chong FS; Li RC
    Phytother Res; 1999 Sep; 13(6):529-31. PubMed ID: 10479768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic lanostane-type triterpenoids from the fruiting bodies of Ganoderma lucidum and their structure-activity relationships.
    Chen S; Li X; Yong T; Wang Z; Su J; Jiao C; Xie Y; Yang BB
    Oncotarget; 2017 Feb; 8(6):10071-10084. PubMed ID: 28052025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH.
    Lin YX; Sun JT; Liao ZZ; Sun Y; Tian XG; Jin LL; Wang C; Leng AJ; Zhou J; Li DW
    Fitoterapia; 2022 Apr; 158():105161. PubMed ID: 35217118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meroterpenoids and alkaloids from
    Zhang JJ; Dong Y; Qin FY; Yan YM; Cheng YX
    Nat Prod Res; 2021 Oct; 35(19):3226-3232. PubMed ID: 31741407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of Ganoderma lucidum triterpenes.
    Wu TS; Shi LS; Kuo SC
    J Nat Prod; 2001 Aug; 64(8):1121-2. PubMed ID: 11520245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.